GlassScriptPhysician profile
Nicole M Tod
NPI 1922537562
$2,365.82
in general payments reported to CMS, 2019-2025
30 companies · $231 in 2025
The $231 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $327 · 2022: $847 · 2023: $425 · 2024: $535 · 2025: $231.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,191.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $488.14 | 2021-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Pfizer INC. | $275.30 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $167.72 | 2023-2024 | Myfembree |
| Agile Therapeutics, INC. | $140.46 | 2021-2022 | |
| Astellas Pharma US INC | $122.25 | 2022-2024 | Veozah |
| Evofem Biosciences, INC. | $112.23 | 2021-2025 | Solosec, Phexx, Phexxi |
| Hologic Sales and Service, LLC | $110.01 | 2022-2025 | Novasure, Myosure Tissue Removal Device |
| Organon LLC | $101.38 | 2022-2024 | |
| Daiichi Sankyo INC. | $89.10 | 2021-2023 | Injectafer |
| Mayne Pharma Commercial LLC | $74.95 | 2022-2025 | |
| Conmed Corporation | $74.76 | 2022-2024 | Airseal |
| Myriad Women'S Health, INC. | $69.38 | 2023 | Myrisk |
| Millicent US INC | $61.83 | 2023-2025 | Intrarosa, Femlyv |
| Exeltis, USA INC. | $52.57 | 2021-2024 | Slynd |
| Axonics, INC. | $50.53 | 2022-2024 | Bulkamid |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $44.34 | 2024 | Zurzuvae, Vumerity |
| Intuitive Surgical, INC. | $42.58 | 2022 | |
| Exact Sciences Corporation | $40.02 | 2024-2025 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $28.87 | 2023 | Exparel |
| Davol INC. | $28.73 | 2025 | Arista |
| Minerva Surgical, INC | $28.42 | 2023 | |
| Avion Pharmaceuticals | $22.92 | 2022 | |
| Shield Therapeutics INC | $22.42 | 2024 | |
| Mycovia Pharmaceuticals, INC. | $21.70 | 2023 | Vivjoa |
| Merck Sharp & Dohme LLC | $19.55 | 2024 | Gardasil 9, Gardasil |
| Kesin Pharma Corporation | $18.19 | 2023 | Likmez |
| Coopersurgical, INC. | $17.95 | 2022 | |
| Scynexis, INC. | $14.38 | 2022 | |
| Aspira Women'S Health INC | $13.58 | 2022 | |
| Channel Medsystems, INC. | $11.56 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Tod listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.